{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:21:04Z","timestamp":1791012064044,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81972380"],"award-info":[{"award-number":["81972380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["822733508"],"award-info":[{"award-number":["822733508"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Key R&D Program of China","award":["2019YFA0906001"],"award-info":[{"award-number":["2019YFA0906001"]}]},{"name":"Beijing Municipal Natural Science Foundation-Jingkai District Innovation Joint Fund","award":["L248054"],"award-info":[{"award-number":["L248054"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2023IR04"],"award-info":[{"award-number":["2023IR04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-02011-x","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:34:39Z","timestamp":1766147679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vitamin C enhances cisplatin sensitivity in bladder cancer via 5hmC-mediated epigenetic modulation of ATF4"],"prefix":"10.1186","volume":"17","author":[{"given":"Chunru","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"1","key":"2011_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2011_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58. https:\/\/doi.org\/10.1038\/s41572-023-00468-9.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"2011_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.trecan.2019.05.011","volume":"5","author":"R Ghandour","year":"2019","unstructured":"Ghandour R, Singla N, Lotan Y. Treatment options and outcomes in nonmetastatic muscle invasive bladder cancer. Trends Cancer. 2019;5(7):426\u201339. https:\/\/doi.org\/10.1016\/j.trecan.2019.05.011.","journal-title":"Trends Cancer"},{"issue":"1","key":"2011_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85(1):17\u201331. https:\/\/doi.org\/10.1016\/j.eururo.2023.08.016.","journal-title":"Eur Urol"},{"issue":"1","key":"2011_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01517-9","volume":"21","author":"ZD Shi","year":"2022","unstructured":"Shi ZD, Hao L, Han XX, et al. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Mol Cancer. 2022;21(1):37. https:\/\/doi.org\/10.1186\/s12943-022-01517-9.","journal-title":"Mol Cancer"},{"key":"2011_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111780","author":"K Zheng","year":"2024","unstructured":"Zheng K, Lyu Z, Chen J, et al. 5-hydroxymethylcytosine: far beyond the intermediate of DNA demethylation. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252111780.","journal-title":"Int J Mol Sci"},{"key":"2011_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113674","volume":"155","author":"D Bisht","year":"2022","unstructured":"Bisht D, Arora A, Sachan M. Role of DNA de-methylation intermediate \u201c5-hydroxymethylcytosine\u201d in ovarian cancer management: a comprehensive review. Biomed Pharmacother Biomed Pharmacother. 2022;155:113674. https:\/\/doi.org\/10.1016\/j.biopha.2022.113674","journal-title":"Biomed Pharmacother Biomed Pharmacother"},{"issue":"21","key":"2011_CR8","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1158\/0008-5472.Can-22-1123","volume":"82","author":"M Sj\u00f6str\u00f6m","year":"2022","unstructured":"Sj\u00f6str\u00f6m M, Zhao SG, Levy S, et al. The 5-hydroxymethylcytosine landscape of prostate cancer. Cancer Res. 2022;82(21):3888\u2013902. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-1123.","journal-title":"Cancer Res"},{"issue":"2","key":"2011_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-022-05406-3","volume":"14","author":"X-J Guo","year":"2023","unstructured":"Guo X-J, Huang X-Y, Yang X, et al. Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC\/PCAF\/AKT axis. Cell Death Dis. 2023;14(2):79. https:\/\/doi.org\/10.1038\/s41419-022-05406-3.","journal-title":"Cell Death Dis"},{"issue":"10","key":"2011_CR10","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1158\/0008-5472.Can-17-3091","volume":"78","author":"C Song","year":"2018","unstructured":"Song C, Wang L, Wu X, et al. PML recruits TET2 to regulate DNA modification and cell proliferation in response to chemotherapeutic agent. Cancer Res. 2018;78(10):2475\u201389. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-3091.","journal-title":"Cancer Res"},{"key":"2011_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ygyno.2024.01.001","volume":"182","author":"M Weigert","year":"2024","unstructured":"Weigert M, Cui XL, West-Szymanski D, et al. 5-hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer. Gynecol Oncol. 2024;182:82\u201390. https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.001.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2011_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0527-7","volume":"10","author":"D Peng","year":"2018","unstructured":"Peng D, Ge G, Gong Y, et al. Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer. Clin Epigenetics. 2018;10(1):94. https:\/\/doi.org\/10.1186\/s13148-018-0527-7.","journal-title":"Clin Epigenetics"},{"key":"2011_CR13","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201745401","author":"G Ge","year":"2018","unstructured":"Ge G, Peng D, Xu Z, et al. Restoration of 5-hydroxymethylcytosine by ascorbate blocks kidney tumour growth. EMBO Rep. 2018. https:\/\/doi.org\/10.15252\/embr.201745401.","journal-title":"EMBO Rep"},{"issue":"3","key":"2011_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.7150\/ijbs.67329","volume":"18","author":"D Peng","year":"2022","unstructured":"Peng D, He A, He S, et al. Ascorbic acid induced TET2 enzyme activation enhances cancer immunotherapy efficacy in renal cell carcinoma. Int J Biol Sci. 2022;18(3):995\u20131007. https:\/\/doi.org\/10.7150\/ijbs.67329.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"2011_CR15","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s43032-022-00866-6","volume":"29","author":"C Yao","year":"2022","unstructured":"Yao C, Lu L, Ji Y, et al. Hypo-hydroxymethylation of Nobox is associated with ovarian dysfunction in rat offspring exposed to prenatal hypoxia. Reprod Sci. 2022;29(5):1424\u201336. https:\/\/doi.org\/10.1007\/s43032-022-00866-6.","journal-title":"Reprod Sci"},{"issue":"4","key":"2011_CR16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1158\/2643-3230.Bcd-21-0143","volume":"3","author":"Y Nakauchi","year":"2022","unstructured":"Nakauchi Y, Azizi A, Thomas D, et al. The cell type-specific 5hmC landscape and dynamics of healthy human hematopoiesis and TET2-mutant preleukemia. Blood Cancer Discov. 2022;3(4):346\u201367. https:\/\/doi.org\/10.1158\/2643-3230.Bcd-21-0143.","journal-title":"Blood Cancer Discov"},{"key":"2011_CR17","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.2147\/cmar.S254671","volume":"13","author":"Y Yan","year":"2021","unstructured":"Yan Y, Jin X, Sun H, et al. MiR-139-5p targetedly regulates YAF2 and mediates the AKT\/P38 MAPK signaling pathway to alleviate the metastasis of non-small cell lung cancer cells and their resistance against cisplatin. Cancer Manag Res. 2021;13:3639\u201350. https:\/\/doi.org\/10.2147\/cmar.S254671.","journal-title":"Cancer Manag Res"},{"key":"2011_CR18","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14827","volume":"11","author":"W Zhu","year":"2023","unstructured":"Zhu W, Huang M, Thakur A, et al. FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer. PeerJ. 2023;11:e14827. https:\/\/doi.org\/10.7717\/peerj.14827.","journal-title":"PeerJ"},{"issue":"1","key":"2011_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01911-w","volume":"10","author":"YS Lin","year":"2024","unstructured":"Lin YS, Sun Z, Shen LS, et al. Arnicolide D induces endoplasmic reticulum stress-mediated oncosis via ATF4 and CHOP in hepatocellular carcinoma cells. Cell Death Discov. 2024;10(1):134. https:\/\/doi.org\/10.1038\/s41420-024-01911-w.","journal-title":"Cell Death Discov"},{"issue":"24","key":"2011_CR20","first-page":"8592","volume":"63","author":"M Tanabe","year":"2003","unstructured":"Tanabe M, Izumi H, Ise T, et al. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines. Cancer Res. 2003;63(24):8592\u20135.","journal-title":"Cancer Res"},{"issue":"7","key":"2011_CR21","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.21873\/anticanres.15135","volume":"41","author":"SK Jang","year":"2021","unstructured":"Jang SK, Hong SE, Lee DH, et al. Inhibition of AKT enhances the sensitivity of NSCLC cells to metformin. Anticancer Res. 2021;41(7):3481\u20137. https:\/\/doi.org\/10.21873\/anticanres.15135.","journal-title":"Anticancer Res"},{"issue":"5","key":"2011_CR22","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1042\/bst20240291","volume":"52","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li J, Tan L, et al. Understanding the role of ten-eleven translocation family proteins in kidney diseases. Biochem Soc Trans. 2024;52(5):2203\u201314. https:\/\/doi.org\/10.1042\/bst20240291.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2011_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01537-x","volume":"8","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang Y, Wang C, et al. TET (Ten-eleven translocation) family proteins: structure, biological functions and applications. Signal Transduct Target Ther. 2023;8(1):297. https:\/\/doi.org\/10.1038\/s41392-023-01537-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2011_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01333-4","volume":"14","author":"J Qi","year":"2022","unstructured":"Qi J, Shi Y, Tan Y, et al. Regional gain and global loss of 5-hydroxymethylcytosine coexist in genitourinary cancers and regulate different oncogenic pathways. Clin Epigenetics. 2022;14(1):117. https:\/\/doi.org\/10.1186\/s13148-022-01333-4.","journal-title":"Clin Epigenetics"},{"key":"2011_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.675780","volume":"12","author":"JP Brabson","year":"2021","unstructured":"Brabson JP, Leesang T, Mohammad S, et al. Epigenetic regulation of genomic stability by vitamin C. Front Genet. 2021;12:675780. https:\/\/doi.org\/10.3389\/fgene.2021.675780.","journal-title":"Front Genet"},{"issue":"2","key":"2011_CR26","first-page":"232","volume":"32","author":"J Li","year":"2016","unstructured":"Li J, Xu Y, Zhang Z, et al. Expression and clinical significance of 5hmC in bladder urothelial carcinoma. Xi bao yu fen zi mian yi xue za zhi Chin J Cell Mol Immunol. 2016;32(2):232\u20135.","journal-title":"Xi bao yu fen zi mian yi xue za zhi Chin J Cell Mol Immunol"},{"issue":"1","key":"2011_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146302","volume":"11","author":"E Munari","year":"2016","unstructured":"Munari E, Chaux A, Vaghasia AM, et al. Global 5-hydroxymethylcytosine levels are profoundly reduced in multiple genitourinary malignancies. PLoS ONE. 2016;11(1):e0146302. https:\/\/doi.org\/10.1371\/journal.pone.0146302.","journal-title":"PLoS ONE"},{"issue":"2","key":"2011_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05406-3","volume":"14","author":"XJ Guo","year":"2023","unstructured":"Guo XJ, Huang XY, Yang X, et al. Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC\/PCAF\/AKT axis. Cell Death Dis. 2023;14(2):79. https:\/\/doi.org\/10.1038\/s41419-022-05406-3.","journal-title":"Cell Death Dis"},{"issue":"21","key":"2011_CR29","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1111\/jcmm.17566","volume":"26","author":"P Xue","year":"2022","unstructured":"Xue P, Zhang G, Zhang H, et al. A miR-15a related polymorphism affects NSCLC prognosis via altering ERCC1 repair to platinum-based chemotherapy. J Cell Mol Med. 2022;26(21):5439\u201351. https:\/\/doi.org\/10.1111\/jcmm.17566.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2011_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44548-y","volume":"13","author":"A Marjamaa","year":"2023","unstructured":"Marjamaa A, Gibbs B, Kotrba C, et al. The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1\/ABCC1) in epithelial ovarian cancer. Sci Rep. 2023;13(1):17476. https:\/\/doi.org\/10.1038\/s41598-023-44548-y.","journal-title":"Sci Rep"},{"key":"2011_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106769","volume":"191","author":"YQ Qu","year":"2023","unstructured":"Qu YQ, Song LL, Xu SW, et al. Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo. Pharmacol Res. 2023;191:106769. https:\/\/doi.org\/10.1016\/j.phrs.2023.106769.","journal-title":"Pharmacol Res"},{"issue":"3","key":"2011_CR32","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1007\/s12640-022-00505-7","volume":"40","author":"X Ma","year":"2022","unstructured":"Ma X, Yang B, Li X, et al. TET enzymes-mediated DNA 5hmC modification in cerebral ischemic and hemorrhagic injury. Neurotox Res. 2022;40(3):884\u201391. https:\/\/doi.org\/10.1007\/s12640-022-00505-7.","journal-title":"Neurotox Res"},{"issue":"1","key":"2011_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11060-018-2845-1","volume":"139","author":"K Bezerra Salom\u00e3o","year":"2018","unstructured":"Bezerra Salom\u00e3o K, Cruzeiro GAV, Bonfim-Silva R, et al. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. J Neuro-Oncol. 2018;139(1):33\u201342. https:\/\/doi.org\/10.1007\/s11060-018-2845-1.","journal-title":"J Neuro-Oncol"},{"issue":"8","key":"2011_CR34","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/15592294.2021.1971372","volume":"17","author":"AV Artemov","year":"2022","unstructured":"Artemov AV, Zhenilo S, Kaplun D, et al. An IDH-independent mechanism of DNA hypermethylation upon VHL inactivation in cancer. Epigenetics. 2022;17(8):894\u2013905. https:\/\/doi.org\/10.1080\/15592294.2021.1971372.","journal-title":"Epigenetics"},{"issue":"4","key":"2011_CR35","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00204-024-03681-x","volume":"98","author":"H Tang","year":"2024","unstructured":"Tang H, Kang R, Liu J, et al. ATF4 in cellular stress, ferroptosis, and cancer. Arch Toxicol. 2024;98(4):1025\u201341. https:\/\/doi.org\/10.1007\/s00204-024-03681-x.","journal-title":"Arch Toxicol"},{"key":"2011_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102132","volume":"92","author":"T Brochard","year":"2023","unstructured":"Brochard T, McIntyre RL, Houtkooper RH, et al. Repurposing nucleoside reverse transcriptase inhibitors (NRTIs) to slow aging. Ageing Res Rev. 2023;92:102132. https:\/\/doi.org\/10.1016\/j.arr.2023.102132.","journal-title":"Ageing Res Rev"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-02011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-02011-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-02011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:34:41Z","timestamp":1766147681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-025-02011-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2011"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-02011-x","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol involving human participants was reviewed and approved by the Ethics Committee of Peking University First Hospital (Approval No. 2023Y407-003). Written informed consent was obtained from all participants or their legal guardians. For animal studies, the protocols were approved by the Animal Ethics Committee of the Peking University First Hospital (Approval No. J2024002) and followed the guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written consent for the publication of any identifying information or images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"203"}}